BioCorRx BICX Stock
BioCorRx Price Chart
BioCorRx BICX Financial and Trading Overview
| BioCorRx stock price | 0.29 USD |
| Previous Close | 1.69 USD |
| Open | 1.69 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.69 - 1.69 USD |
| 52 Week Range | 0.22 - 2.79 USD |
| Volume | 50 USD |
| Avg. Volume | 457 USD |
| Market Cap | 14.31M USD |
| Beta (5Y Monthly) | 0.861619 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.49 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.1 USD |
BICX Valuation Measures
| Enterprise Value | 15.89M USD |
| Trailing P/E | N/A |
| Forward P/E | -24.142859 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 61.203426 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 67.992 |
| Enterprise Value/EBITDA | -3.49 |
Trading Information
BioCorRx Stock Price History
| Beta (5Y Monthly) | 0.861619 |
| 52-Week Change | -23.87% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.79 USD |
| 52 Week Low | 0.22 USD |
| 50-Day Moving Average | 1.84 USD |
| 200-Day Moving Average | 1.74 USD |
BICX Share Statistics
| Avg. Volume (3 month) | 457 USD |
| Avg. Daily Volume (10-Days) | 440 USD |
| Shares Outstanding | 8.47M |
| Float | 3.5M |
| Short Ratio | N/A |
| % Held by Insiders | 67.40% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1959.94% |
| Gross Margin | 90.40% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -308.94% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 233.77K USD |
| Revenue Per Share (ttm) | 0.03 USD |
| Quarterly Revenue Growth (yoy) | 97.09% |
| Gross Profit (ttm) | N/A |
| EBITDA | -4554404 USD |
| Net Income Avi to Common (ttm) | -4434625 USD |
| Diluted EPS (ttm) | -0.6 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 203.69K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 1.9M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.059 |
| Book Value Per Share (mrq) | -1.077 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1566456 USD |
| Levered Free Cash Flow (ttm) | -1321047 USD |
Profile of BioCorRx
| Country | United States |
| State | CA |
| City | Anaheim |
| Address | 2390 East Orangewood Avenue |
| ZIP | 92806 |
| Phone | 714 462 4880 |
| Website | https://www.biocorrx.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
Q&A For BioCorRx Stock
What is a current BICX stock price?
BioCorRx BICX stock price today per share is 0.29 USD.
How to purchase BioCorRx stock?
You can buy BICX shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioCorRx?
The stock symbol or ticker of BioCorRx is BICX.
Which industry does the BioCorRx company belong to?
The BioCorRx industry is Medical Care Facilities.
How many shares does BioCorRx have in circulation?
The max supply of BioCorRx shares is 16.1M.
What is BioCorRx Price to Earnings Ratio (PE Ratio)?
BioCorRx PE Ratio is now.
What was BioCorRx earnings per share over the trailing 12 months (TTM)?
BioCorRx EPS is -0.49 USD over the trailing 12 months.
Which sector does the BioCorRx company belong to?
The BioCorRx sector is Healthcare.